Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CHRS
#3090
Coherus Oncology, Inc. Common Stock
1.740
0
USD
+2.96%
Sector:
Atención Sanitaria
Básica:
USD
Profit Currency:
USD
Rango diario
Rango anual
Cambio diario
+2.96%
Monthly Change
+9.43%
6 month change
+8.07%
Cambio anual
+8.07%
Cierres anteriores
1.690
0
Open
1.740
0
Bid
Ask
Low
1.740
0
High
1.740
0
Volumen
40
Markets
Acciones
Atención Sanitaria
CHRS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
115.9 M
115.93 M
116.23 M
120.87 M
149.89 M
—
Valuation ratios
Enterprise value
33.95 M
11.15 M
-131.9 M
94.88 M
123.96 M
98.09 M
Price to earnings ratio
5.52
-0.7
0.48
1.25
0.99
2.02
Price to sales ratio
0.59
0.24
0.25
0.68
3.94
5.11
Price to cash flow ratio
7.75
-108.9
1.06
2.12
1.2
-104.51
Price to book ratio
1.2
0.19
0.16
0.36
2.73
3.44
Enterprise value to EBITDA ratio
0.28
0.38
2.28
-0.99
57.18
58.84
Profitability ratios
Return on assets %
-0.22
0.15
0.68
0.07
-0.86
0.04
Return on equity %
-0.74
0.31
2.48
0.4
-3.64
-0.44
Return on invested capital %
—
—
—
—
-45.38
—
Gross margin %
55.06
65.09
66.89
67.84
68.27
268.09
Operating margin %
-17.16
597.91
443.59
383.14
359.9
1 784.54
EBITDA margin %
16.86
-606.41
-450.58
-388.89
-364.57
-1 810.45
Net margin %
-39.48
744.43
2 903.91
307.07
-1 740.22
2 215.19
Liquidity ratios
Quick ratio
0.96
1.2
1.43
1.23
1.45
5.31
Current ratio
1.21
1.22
1.44
1.24
1.47
5.37
Inventory turnover
1.9
0.07
0.85
1.13
1.55
3.6
Asset turnover
0.52
0.02
0.03
0.02
0.03
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.51
0.62
—
—
—
—
Long term debt to total equity ratio
1.73
1.25
—
—
—
—
Per share metrics
Operating cash flow per share
-0.25
0.22
0.4
0.4
0.17
1.19
EBIT per share
0.36
-0.4
-0.4
-0.39
-0.4
-1.59
EBITDA per share
0.36
-0.4
-0.4
-0.39
-0.4
-1.58
Total debt per share
—
—
—
—
—
—
Cash per share
1.1
0.71
2.05
1.65
1.47
5.88
Net current asset value per share
2.97
2.68
3.28
3.97
1.76
11.68
Tangible book value per share
0.68
1.13
0.58
0.33
0.13
2.16
Working capital per share
0.51
0.48
1
0.76
0.57
2.81
Book value per share
1.15
1.58
1.03
0.76
0.52
3.89
Noticias
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Coherus BioSciences en The Citizens Conference: Giro estratégico hacia la oncología
Coherus BioSciences en Citizens Conference: giro estratégico oncológico
Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift
Oppenheimer reitera calificación de Mejor Rendimiento para Coherus Biosciences
Oppenheimer reitera calificación Outperform para Coherus Biosciences
Oppenheimer reiterates Coherus Biosciences stock rating at Outperform
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates
Coherus BioSciences se ubica en línea con las previsiones de BPA en el primer trimestre del año
Coherus BioSciences cumple las previsiones de BPA en el primer trimestre del año
Coherus BioSciences earnings matched, revenue fell short of estimates